Stockreport

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

Beyond Air, Inc.  (XAIR) 
PDF GARDEN CITY, N.Y., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmace [Read more]